High Prevalence of Hepatitis B Virus Infection in the Age Range of 20-39 Years Old Individuals in Lome

M. Kolou, G. Katawa, M. Salou, Komlan Selom Gozo-Akakpo, S. Dossim, A. Kwarteng, M. Prince-david
{"title":"High Prevalence of Hepatitis B Virus Infection in the Age Range of 20-39 Years Old Individuals in Lome","authors":"M. Kolou, G. Katawa, M. Salou, Komlan Selom Gozo-Akakpo, S. Dossim, A. Kwarteng, M. Prince-david","doi":"10.2174/1874357901710011001","DOIUrl":null,"url":null,"abstract":"Background: Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). It affects all women and men irrespective of age. Although sub-Saharan Africa is an area of high prevalence of this disease, data on the prevalence of acute and chronic HBV infections in this region remain to be widely documented. Objective: This study aimed to investigate the prevalence of HBV in relation to age in Centre Hospitalier Universitaire Campus (CHU-C), one of the two teaching hospitals of Lome, Togo. Method: The present study is a cross-sectional study about the prevalence of hepatitis B surface antigen (HBsAg) carriage from 2009 to 2011. All study participants were screened for HBsAg at the Immunology laboratory of CHU Campus of Lome. Results: One thousand two hundred individuals were screened for HBsAg from 2009-2011. The overall prevalence of HBV infection was 19.08%. This prevalence was significantly higher in men (25.00%) than women (14.80%). The highest prevalence of HBV was observed in age range of 20-29 years and 30-39 years with respectively 26.33% and 21.67%. The lowest prevalence was 6.08%, found in people over 50 years. Concerning the clinical indication of the test, the prevalence during the clinical abnormalities related to liver (CARL) was the highest (26.21%), followed by the systematic screening (SS) with 20.25% while the pre-operative assessment (POA) showed the lowest prevalence with 5.56%. Conclusion: The study shows the high prevalence of HBsAg carriage in young people. This could be used to enhance prevention and treatment of HBV infection in Togo.","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"4 1","pages":"1 - 7"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Virology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874357901710011001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

Abstract

Background: Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). It affects all women and men irrespective of age. Although sub-Saharan Africa is an area of high prevalence of this disease, data on the prevalence of acute and chronic HBV infections in this region remain to be widely documented. Objective: This study aimed to investigate the prevalence of HBV in relation to age in Centre Hospitalier Universitaire Campus (CHU-C), one of the two teaching hospitals of Lome, Togo. Method: The present study is a cross-sectional study about the prevalence of hepatitis B surface antigen (HBsAg) carriage from 2009 to 2011. All study participants were screened for HBsAg at the Immunology laboratory of CHU Campus of Lome. Results: One thousand two hundred individuals were screened for HBsAg from 2009-2011. The overall prevalence of HBV infection was 19.08%. This prevalence was significantly higher in men (25.00%) than women (14.80%). The highest prevalence of HBV was observed in age range of 20-29 years and 30-39 years with respectively 26.33% and 21.67%. The lowest prevalence was 6.08%, found in people over 50 years. Concerning the clinical indication of the test, the prevalence during the clinical abnormalities related to liver (CARL) was the highest (26.21%), followed by the systematic screening (SS) with 20.25% while the pre-operative assessment (POA) showed the lowest prevalence with 5.56%. Conclusion: The study shows the high prevalence of HBsAg carriage in young people. This could be used to enhance prevention and treatment of HBV infection in Togo.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
洛美20-39岁人群乙型肝炎病毒感染率高
背景:乙型肝炎是由乙型肝炎病毒(HBV)引起的一种肝脏感染。它影响所有男女,不论年龄大小。尽管撒哈拉以南非洲是该疾病的高发地区,但该地区急性和慢性乙型肝炎病毒感染的流行数据仍有待广泛记录。目的:本研究旨在调查多哥洛美两所教学医院之一的Centre Hospitalier Universitaire Campus (chuc)中HBV与年龄的关系。方法:对2009 ~ 2011年重庆市乙型肝炎表面抗原(HBsAg)携带情况进行横断面调查。所有研究参与者在洛美CHU校区免疫学实验室进行HBsAg筛查。结果:2009-2011年共对1200人进行HBsAg筛查。HBV感染总患病率为19.08%。男性的患病率(25.00%)明显高于女性(14.80%)。乙肝病毒感染率最高的年龄段为20 ~ 29岁和30 ~ 39岁,分别为26.33%和21.67%。最低患病率为6.08%,在50岁以上人群中发现。在临床适应症方面,临床与肝脏相关的异常(CARL)的患病率最高(26.21%),其次是系统筛查(SS),患病率为20.25%,而术前评估(POA)的患病率最低,为5.56%。结论:青年人群HBsAg携带率较高。这可用于加强多哥乙型肝炎病毒感染的预防和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Evolutionary Significance of Generalist Viruses with Special Emphasis on Plant Viruses and their Hosts Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic Iota-Carrageenan as an Antiviral Treatment for the Common Cold A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2 Evolving Rotaviruses, Interspecies Transmission and Zoonoses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1